Key points are not available for this paper at this time.
ARRY-142886 is a potent and selective MEK1/2 inhibitor that is highly active in both in vitro and in vivo tumor models. This compound is currently being investigated in clinical studies.
Yeh et al. (Thu,) studied this question.